AAminove
Back to library

Thymosin Alpha-1

Human RCT

Also known as: Tα1, Zadaxin

ImmuneImmune modulation (approved in some countries)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

An immunomodulatory peptide approved in several countries (e.g. as Zadaxin) for hepatitis and as a vaccine adjuvant. Approval status varies by region.

Mechanism

Modulates T-cell function and innate immunity.

Evidence

Human RCTWhat does this mean?

Moderate-to-strong within specific approved indications and regions; general immune-boosting claims are weaker.

Community-reported information

Where approved, dosed per label and clinician. Outside those, anecdotal; general information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

~2 hours.

Storage

Refrigerate.

Commonly reported side effects

  • Injection-site reactions
  • Generally well tolerated in trials

Legal status by region

  • USNot FDA-approved; approved in various other countries.
  • GBNot licensed for general use in the UK.

Legal status changes over time; verify locally before relying on this.

Citations